<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>K-Ras mutations are frequent in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>), albeit K-Ras is the only Ras isoform that can elicit <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="1" pm="."><plain>Here, we show that mutant K-Ras directly binds to the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor RASSF1A to activate the apoptotic MST2-LATS1 pathway </plain></SENT>
<SENT sid="2" pm="."><plain>In this pathway LATS1 binds to and sequesters the ubiquitin ligase Mdm2 causing stabilization of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor p53 and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="3" pm="."><plain>However, mutant Ras also stimulates autocrine activation of the EGF receptor (EGFR) which counteracts mutant K-Ras-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="4" pm="."><plain>Interestingly, this protection requires the <z:mp ids='MP_0002169'>wild-type</z:mp> K-Ras allele, which inhibits the MST2 pathway in part via AKT activation </plain></SENT>
<SENT sid="5" pm="."><plain>Confirming the pathophysiological relevance of the molecular findings, we find a negative correlation between K-Ras mutation and MST2 expression in human <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> mouse models </plain></SENT>
<SENT sid="6" pm="."><plain>The small number of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> with co-expression of mutant K-Ras and MST2 has elevated <z:mpath ids='MPATH_3'>apoptosis</z:mpath> rates </plain></SENT>
<SENT sid="7" pm="."><plain>Thus, in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, mutant K-Ras transformation is supported by the <z:mp ids='MP_0002169'>wild-type</z:mp> allele </plain></SENT>
</text></document>